0.035742 0.000000 0.000000 0.000000 0.033281 0.000000 0.000000 0.000000 0.018563 0.00000 0.00000 0.00000 0000-0002-0247-9495 Rhys, G.G. 0000-0003-1243-3105 Wood, C.W. 0000-0003-2203-0027 Beesley, J.L. 0000-0002-3575-5513 Brady, R.L. 0000-0002-0394-3202 Woolfson, D.N. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 27.978 30.047 53.871 C2 H4 O 44.053 ACETYL GROUP non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C6 H13 N O4 S 195.237 2-(N-MORPHOLINO)-ETHANESULFONIC ACID non-polymer H2 N 16.023 AMINO GROUP non-polymer C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking US J.Am.Chem.Soc. JACSAT 1520-5126 141 8787 8797 10.1021/jacs.8b13354 31066556 Navigating the Structural Landscape of De Novo alpha-Helical Bundles. 2019 0000-0002-0247-9495 0000-0003-1243-3105 0000-0003-2203-0027 0000-0002-1476-2044 0000-0002-1066-1369 0000-0002-0394-3202 80 1 N PIXEL 2018-05-19 DECTRIS PILATUS 6M-F SINGLE WAVELENGTH M x-ray 1 0.9795 1.0 I04 Diamond 0.9795 SYNCHROTRON DIAMOND BEAMLINE I04 3259.860 CC-Hex*-L24H 2 syn polymer 195.237 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 1 syn non-polymer 18.015 water 28 nat water no yes (ACE)GELKAIAQELKAIAKELKAIAWEHKAIAQG(NH2) XGELKAIAQELKAIAKELKAIAWEHKAIAQGX B,A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n 1 1.74 29.17 VAPOR DIFFUSION, SITTING DROP 6.5 0.8 M sodium citrate 293 citation citation_author pdbx_database_proc repository Initial release Data collection Database references 1 0 2019-05-22 1 1 2019-06-19 _citation.journal_volume _citation.page_first _citation.page_last _citation.title _citation_author.identifier_ORCID _citation_author.name United Kingdom Biotechnology and Biological Sciences Research Council BB/J014400/1 United Kingdom Engineering and Physical Sciences Research Council EP/G036764/1 Belgium European Research Council 340764 United Kingdom Biotechnology and Biological Sciences Research Council BB/R00661X/1 United Kingdom Engineering and Physical Sciences Research Council EP/K03927X/1 N PDBE Y PDBE 2018-12-09 REL REL MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HOH water 32630 synthetic construct sample 1 32 MES 1 2 MES MES 101 B HOH 15 3 HOH HOH 201 B HOH 7 3 HOH HOH 202 B HOH 25 3 HOH HOH 203 B HOH 10 3 HOH HOH 204 B HOH 9 3 HOH HOH 205 B HOH 1 3 HOH HOH 206 B HOH 4 3 HOH HOH 207 B HOH 5 3 HOH HOH 208 B HOH 18 3 HOH HOH 209 B HOH 12 3 HOH HOH 210 B HOH 21 3 HOH HOH 211 B HOH 16 3 HOH HOH 212 B HOH 17 3 HOH HOH 213 B HOH 27 3 HOH HOH 101 A HOH 8 3 HOH HOH 102 A HOH 26 3 HOH HOH 103 A HOH 13 3 HOH HOH 104 A HOH 2 3 HOH HOH 105 A HOH 28 3 HOH HOH 106 A HOH 23 3 HOH HOH 107 A HOH 11 3 HOH HOH 108 A HOH 22 3 HOH HOH 109 A HOH 20 3 HOH HOH 110 A HOH 14 3 HOH HOH 111 A HOH 3 3 HOH HOH 112 A HOH 24 3 HOH HOH 113 A HOH 6 3 HOH HOH 114 A HOH 29 3 HOH HOH 115 A ACE 0 n 1 ACE 0 B GLY 1 n 2 GLY 1 B GLU 2 n 3 GLU 2 B LEU 3 n 4 LEU 3 B LYS 4 n 5 LYS 4 B ALA 5 n 6 ALA 5 B ILE 6 n 7 ILE 6 B ALA 7 n 8 ALA 7 B GLN 8 n 9 GLN 8 B GLU 9 n 10 GLU 9 B LEU 10 n 11 LEU 10 B LYS 11 n 12 LYS 11 B ALA 12 n 13 ALA 12 B ILE 13 n 14 ILE 13 B ALA 14 n 15 ALA 14 B LYS 15 n 16 LYS 15 B GLU 16 n 17 GLU 16 B LEU 17 n 18 LEU 17 B LYS 18 n 19 LYS 18 B ALA 19 n 20 ALA 19 B ILE 20 n 21 ILE 20 B ALA 21 n 22 ALA 21 B TRP 22 n 23 TRP 22 B GLU 23 n 24 GLU 23 B HIS 24 n 25 HIS 24 B LYS 25 n 26 LYS 25 B ALA 26 n 27 ALA 26 B n 28 27 B n 29 28 B n 30 29 B n 31 30 B n 32 31 B ACE 0 n 1 ACE 0 A GLY 1 n 2 GLY 1 A GLU 2 n 3 GLU 2 A LEU 3 n 4 LEU 3 A LYS 4 n 5 LYS 4 A ALA 5 n 6 ALA 5 A ILE 6 n 7 ILE 6 A ALA 7 n 8 ALA 7 A GLN 8 n 9 GLN 8 A GLU 9 n 10 GLU 9 A LEU 10 n 11 LEU 10 A LYS 11 n 12 LYS 11 A ALA 12 n 13 ALA 12 A ILE 13 n 14 ILE 13 A ALA 14 n 15 ALA 14 A LYS 15 n 16 LYS 15 A GLU 16 n 17 GLU 16 A LEU 17 n 18 LEU 17 A LYS 18 n 19 LYS 18 A ALA 19 n 20 ALA 19 A ILE 20 n 21 ILE 20 A ALA 21 n 22 ALA 21 A TRP 22 n 23 TRP 22 A GLU 23 n 24 GLU 23 A HIS 24 n 25 HIS 24 A n 26 25 A n 27 26 A n 28 27 A n 29 28 A n 30 29 A n 31 30 A n 32 31 A 1.5855 0.3720 2.0894 2.6954 0.3307 9.7632 0.0873 0.0706 0.1675 -0.2051 -0.1713 -0.1719 -0.1865 0.0748 0.0840 0.0464 0.0202 0.0314 0.0220 0.0204 0.0413 refined 3.1630 5.9680 18.3090 X-RAY DIFFRACTION 0.9850 -0.1450 -0.2244 1.6972 -1.1125 9.2622 0.0033 0.0916 0.1079 -0.2653 -0.0974 -0.2558 -0.0113 0.2788 0.0941 0.0585 0.0247 0.0418 0.0429 0.0241 0.0469 refined 6.6700 0.3230 12.2540 X-RAY DIFFRACTION B 0 B 25 X-RAY DIFFRACTION 1 A 1 A 24 X-RAY DIFFRACTION 2 author_and_software_defined_assembly PISA 4 tetrameric equilibrium centrifugation 5170 -50 6430 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 2_555 -x,-y,z crystal symmetry operation 0.0000000000 0.0000000000 0.0000000000 1 B CA ALA 26 A CA ALA 27 1 Y 1 B C ALA 26 A C ALA 27 1 Y 1 B O ALA 26 A O ALA 27 1 Y 1 B CB ALA 26 A CB ALA 27 1 Y 1 A C HIS 24 B C HIS 25 1 Y 1 A O HIS 24 B O HIS 25 1 Y 1 A CB HIS 24 B CB HIS 25 1 Y 1 A CG HIS 24 B CG HIS 25 1 Y 1 A ND1 HIS 24 B ND1 HIS 25 1 Y 1 A CD2 HIS 24 B CD2 HIS 25 1 Y 1 A CE1 HIS 24 B CE1 HIS 25 1 Y 1 A NE2 HIS 24 B NE2 HIS 25 1 Y 1 B ILE 27 A ILE 28 1 Y 1 B ALA 28 A ALA 29 1 Y 1 B GLN 29 A GLN 30 1 Y 1 B GLY 30 A GLY 31 1 Y 1 B NH2 31 A NH2 32 1 Y 1 A LYS 25 B LYS 26 1 Y 1 A ALA 26 B ALA 27 1 Y 1 A ILE 27 B ILE 28 1 Y 1 A ALA 28 B ALA 29 1 Y 1 A GLN 29 B GLN 30 1 Y 1 A GLY 30 B GLY 31 1 Y 1 A NH2 31 B NH2 32 1 Y 1 B LYS 25 -38.98 -36.58 29.959 0.49 0.00 0.00 -1.69 0.00 1.20 0.959 0.934 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS 0.24689 0.21067 0.21235 1.41 26.95 411 8356 4.7 95.00 3.427 0.060 RANDOM 1 THROUGHOUT MOLECULAR REPLACEMENT 0.078 0.082 0.80 0.80 1.00 1.41 26.95 28 422 12 0 382 0.009 0.013 409 0.001 0.017 428 1.479 1.624 547 1.486 1.586 996 3.008 5.000 49 32.106 24.375 16 14.773 15.000 84 0.076 0.200 53 0.008 0.020 433 0.003 0.020 67 3.562 1.882 202 3.556 1.881 202 4.847 2.772 251 4.844 2.780 252 7.312 2.766 207 5.933 2.706 205 10.827 3.917 297 9.802 25.590 477 9.826 25.783 478 1 B 1 619 X-RAY DIFFRACTION interatomic distance 0.11 0.05 2 A 1 619 X-RAY DIFFRACTION interatomic distance 0.11 0.05 0.386 0.402 1.447 22 430 20 69.22 1.41 27.96 6Q5L 8784 0.998 0.088 0.037 0.092 0.86 1 11.0 9.7 95.2 0.857 1.41 1.45 1.0 452 0.492 0.665 1.008 0.39 1 3.5 70.9 0.104 6.31 27.96 23.0 136 0.997 0.044 0.110 1.18 1 9.1 98.7 refinement REFMAC 5.8.0232 data reduction DIALS 1.9.3-gb491019a data scaling Aimless 0.6.2 phasing PHASER 2.8.2 N CC-Hex-L24H Crystal structure of a CC-Hex mutant that forms an antiparallel four-helix coiled coil CC-Hex*-L24H 1 N N 1 N N 2 N N 3 N N 3 N N B GLY 1 A GLY 2 HELX_P B LYS 25 A LYS 26 1 AA1 25 A GLY 1 B GLY 2 HELX_P A HIS 24 B HIS 25 1 AA2 24 covale 1.342 both B ACE 0 A C ACE 1 1_555 B GLY 1 A N GLY 2 1_555 covale 1.326 both A ACE 0 B C ACE 1 1_555 A GLY 1 B N GLY 2 1_555 DE NOVO PROTEIN coiled coil, tetramer, synthetic, antiparallel, cc-hex, DE NOVO PROTEIN B A B 1 B 23 0 A 1 A 23 0 6Q5L PDB 1 1 6Q5L 0 31 6Q5L 0 31 6Q5L B 1 1 32 0 31 6Q5L 0 31 6Q5L A 1 1 32 binding site for residue MES B 101 B MES 101 Software 4 binding site for Di-peptide ACE A 0 and GLY A 1 A ACE 0 Software 8 A HOH 106 E HOH 4 1_556 B GLU 9 A GLU 10 4 4_556 B LYS 25 A LYS 26 4 1_555 B ALA 26 A ALA 27 4 1_555 A GLU 2 B GLU 3 8 1_555 A LEU 3 B LEU 4 8 1_555 A LYS 4 B LYS 5 8 1_555 A ALA 5 B ALA 6 8 1_555 A HOH 101 E HOH 8 1_555 B LYS 15 A LYS 16 8 3_546 B ALA 19 A ALA 20 8 3_546 B ALA 21 A ALA 22 8 1_555 18 P 21 21 2